Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts

The New England Journal of Medicine·May 13

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Ensitrelvir has been associated with a reduced risk of covid-19 among household contacts. The antiviral has been reported to cut the risk of covid-19 in this group, with one study finding a reduction of two-thirds. The FDA has approved ensitrelvir for postexposure prophylaxis of covid-19 in adolescents and adults, making it an option for those exposed to the virus.

Full coverage

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

2 Minute Medicine·May 26

Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds

CIDRAP·May 14

FDA Approves Ensitrelvir for Postexposure Prophylaxis of COVID-19 in Adolescents and Adults

Pharmacy Times·Jun 2

FDA Approves Ensitrelvir as First Oral COVID-19 Postexposure Prophylaxis Option

Patient Care Online·Jun 1

View original report at The New England Journal of Medicine ↗

Fetching the latest headlines…

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts

Full coverage

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds

Oral Antiviral Xocova Approved for COVID-19 Post-Exposure Prophylaxis

Ensitrelvir Reduces COVID Risk Among Household Contacts Post-Exposure

FDA Approves Oral Ensitrelvir for COVID-19 Postexposure Prophylaxis

Ensitrelvir cuts household COVID-19 risk when given after exposure

FDA Approves Ensitrelvir for Postexposure Prophylaxis of COVID-19 in Adolescents and Adults

FDA Approves Ensitrelvir as First Oral COVID-19 Postexposure Prophylaxis Option